Profile: ArthroCare Corp (ARTC.O)
6 Mar 2014
ArthroCare Corporation (ArthroCare), incorporated on April 29, 1993, is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. The Company’s devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its Coblation technology. This technology dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology, including its OPUS line of fixation products, as well as re-usable surgical instruments. ArthroCare’s two core product consists of sports medicine and ear, nose, and throat (ENT), as well as other areas, such as spine, wound care, urology and gynecology. It’s Sports Medicine, ENT and other products are marketed and sold through two principal geographic distribution channels: Americas (North and South America) and International (all other geographies). Many of ArthroCare’s products are based on Coblation technology, which uses bipolar radiofrequency energy to generate a focused plasma field to remove and shape soft tissues, such as cartilage and tendons. In July 2013, ArthroCare Corp completed the acquisition of ENTrigue Surgical, Inc.
ArthroCare’s Sports Medicine product area focuses on the development, production and marketing of surgical products used in the treatment of soft tissue injuries, mostly in the shoulder, knees and hips. During the year ended December 31, 2011, Sports Medicine accounted for 67.5% of its total product sales. It also contracts manufacture disposable surgical devices and implants based on its technologies for other companies. The ArthroCare Sports Medicine product portfolio includes two platforms, which consists of Coblation and Soft-Tissue Fixation.
The Coblation series of disposable, surgical wands, called ArthroWands. ArthroWands is designed for single patient use to treat orthopedic conditions, including injuries of the shoulder, knee, hip, foot, ankle, elbow, and wrist. ArthroWands are used with a controller. The Soft-Tissue Fixation product portfolio includes a line of implants and instruments, including knotless and anchors for rotator cuff and labrum repairs in the shoulder, screws for ligament reconstruction in the knee, a variety of arthroscopic suture passers, and an offering of associated reusable hand-held instruments, procedural kits, and accessories.
In ENT, the Company focuses on the development, production and marketing of surgical products used in the treatment of conditions typically treated by ENT healthcare professionals. During 2011, ArthroCare’s ENT product area accounted for 29.6% of its total product sales. In ENT it produces products for the removal of tonsils and adenoids. In ENT ArthroCare has two product lines, which include The ENT Wands Product Line and The Rapid Rhino Product Line. ENT has developed a variety of products for use by ENT surgeons for general head, neck and oral surgical procedures, including sinus surgery, the treatment of snoring, reduction of nasal turbinates, and adenoid and tonsil removal.
ENT markets three categories of disposable devices, or wands, to address the ENT Market in suction wands, channeling wands and excision wands, each of, which uses Coblation technology. During a tonsillectomy, suction wands simultaneously ablate and remove tissue providing the surgeon enhanced visibility and shortening anesthesia time. Channeling wands provides ablation and thermal coagulation during turbinate reduction procedures to relieve nasal obstructions and stiffen the soft palate for the treatment of snoring. Excision wands provide precise dissection of soft tissue.
Applied Therapeutics, Inc.’s, (ATI’s) carboxymethyl-cellulose based packing and tamponade products are used in situations of nosebleed, or epistaxis, treatments, which are treated in an emergency room setting or surgicenter. ArthroCare’s Rapid Rhino product line includes the dissolvable Stammberger Sinus Dressing and Sinu Knit, which are used after endoscopic sinus surgery to control minor bleeding, facilitate epithelial healing and preserve the spatial integrity of the sinus area. Its Rapid Rhino product line also includes epistaxis balloon tamponade products, which are used in the hospital emergency room environment to control chronic nosebleeds.
ArthroCare develops, produces and markets surgical products used in the treatment of spine related and other conditions. The Company’s other products include SpineWand Product Line and WoundWand Debridement Device. The SpineWand devices use Coblation-based technology to treat soft tissue, which include intervertebral disc and vertebrae, conditions in the spine. The Company’s Plasma Disc Decompression (PDD), SpineWands are used for the treatment of contained herniated discs. The Cavity SpineWand is used to reduce the size of malignant lesions within the vertebrae in patients suffering from spinal compression fractures resulting from benign or malignant tumors.
The Company competes with Medtronic, Inc., Smith & Nephew, Stryker Corporation, Johnson & Johnson, Olympus and Arthrex, Inc.
Building 1 7000 W. William Canno
Austin TX 78735
Company Web Links
- Smith&Nephew in $1.7 billion deal to tackle sports injuries
- UPDATE 3-Smith&Nephew in $1.7 bln deal to tackle sports injuries
- Smith & Nephew buys sports medicine firm ArthroCare for $1.7 bln
- ArthroCare signs deal to end fraud prosecution, to pay $30 million fine
- ArthroCare signs deal to end fraud prosecution, to pay $30 mln fine